Musa Canan

Musa Canan

Auto-generated profile, based on publicly available information

Musa Canan

Department of Neurosurgery, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
AOAli Serdar Oguzoglu
Ali Serdar Oguzoglu
HAHalil Asci
Halil Asci
SASanem Asci
Sanem Asci
MCMusa Canan
Musa Canan
RTRumeysa Taner
Rumeysa Taner
OOOzlem Ozmen
Ozlem Ozmen

24 September 2026 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
AOAli Serdar Oğuzoğlu
Ali Serdar Oğuzoğlu
MCMusa Canan
Musa Canan
FOFurkan Çağrı Oğuzlar
Furkan Çağrı Oğuzlar
HAHalil Aşçı
Halil Aşçı
OOOzlem Ozmen
Ozlem Ozmen
ObjectiveTraumatic brain injury (TBI) is known to trigger systemicinflammatory responses, leading to damage indistant organs such as the liver. Amantadine (AMA),an NMDA receptor antagonist, exhibits both anti-inflammatoryand neuroprotective properties. This studyinvestigated the protective effects of AMA against liverinjury secondary to TBI in a rat model.Material and MethodForty male Wistar albino rats were randomly assignedto four groups: Control, Trauma (TRA), TRA+AMA-1,and TRA+AMA-7. TBI was induced by the Marmarouweight-drop method. AMA (45 mg/kg/day, intraperitoneal)was administered for 1 and 7 days post-TBI.Liver tissues were harvested and evaluated via histopathologicalscoring and immunohistochemical analysisfor tumor necrosis factor alpha (TNF-α), interleukin6 (IL-6), and interferon beta (IFN-β).ResultsTBI significantly elevated hepatic expression ofpro-inflammatory cytokines (IFN-β, IL-6, TNF-α) andcaused marked histological damage, including hyperemia,hemorrhage, inflammation, and necrosis. AMAtreatment markedly reduced these cytokine expressionsand ameliorated histopathological alterations.The TBI+AMA-7 group exhibited substantial recoverycompared to the TBI group, indicating an associationbetween amantadine treatment and reduced histopathologicalliver injury.ConclusionThe trauma group demonstrated significantly higherhistopathological liver injury scores compared withthe control group. AMA treatment was associatedwith reduced histopathological alterations and lowerimmunoreactivity of pro-inflammatory cytokines comparedwith the untreated trauma group.

29 June 2026 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
AOAli Serdar Oğuzoğlu
Ali Serdar Oğuzoğlu
MCMusa Canan
Musa Canan
FOFurkan Çağrı Oğuzlar
Furkan Çağrı Oğuzlar
HAHalil Aşçı
Halil Aşçı
OOOzlem Ozmen
Ozlem Ozmen
ObjectiveTraumatic brain injury (TBI) frequently causes secondary damage in distant organs, particularly the lungs, contributing to poor clinical outcomes. We aimed to assess whether tasimelteon (TASI), a melatonin receptor agonist, could mitigate pulmonary injury resulting from TBI in a rat model.Material and MethodForty male Wistar albino rats were randomly allocated to four distinct experimental groups: control, trauma (TRA), TRA + TASI 1mg/kg, and TRA + TASI 10mg/ kg. TBI was induced via Marmarou’s weight-drop model. Lung tissue samples were evaluated 24 hours after TBI via histopathological and immunohistochemical analyses targeting B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and Tumor Necrosis Factor-alpha (TNF-α).ResultsTBI induced significant alveolar damage, hyperemia, edema, and elevated Bax and TNF-α expression while reducing anti-apoptotic Bcl-2 levels. TASI, particularly at 10 mg/kg, significantly reversed these histological and molecular alterations (p < 0.05).ConclusionTASI provides dose-dependent protection against TBI-induced lung injury through modulation of apoptotic and inflammatory pathways. Its melatoninergic actions may represent a promising therapeutic option for managing multi-organ complications post-TBI.

19 September 2024 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
AOAli Serdar Oğuzoğlu
Ali Serdar Oğuzoğlu
HAHalil Aşçı
Halil Aşçı
MCMusa Canan
Musa Canan
NŞNilgün Şenol
Nilgün Şenol
OOOzlem Ozmen
Ozlem Ozmen
Objective: Oxidant and inflammatory substances released into the blood due to subarachnoidal hemorrhage (SAH) can pass into the peripheral compartment, causing distant organ damage due to blood-brain barrier permeability caused by oxidative stress, inflammation, and apoptosis. This study aimed to demonstrate the secondary damage to peripheral organs, including the lung, kidney, and liver, resulting from SAH. Material and Method: Twenty rats were divided into sham and SAH groups, each consisting of ten animals. In the SAH group animals, 0.3 mL autologous blood taken from the tail artery was injected into the cisterna magna for 2 minutes. Seven days after SAH formation, all animals were euthanized under anesthesia. Following decapitation, brain tissues, lung, liver, and kidney tissues were placed in 10% formaldehyde for histopathological and immunohistochemical analysis. Results: In the SAH group, neuronal degeneration in the cerebral cortex, and hyperemia and hemorrhage in the lung, kidney, and liver were observed histopathologically. In immunohistochemical examinations, decreased expression of brain-derived neurotrophic factor (BDNF) and neurofilament (NF) in the cerebral cortex, cerebellum, and hippocampus sections; In lung tissues, enhanced caspase (Cas)-3, hypoxia-inducible factor 1 alpha (Hif-1α) and nuclear factor kappa beta (NF-κB) expressions in the lung, Cas-5, cyclooxygenase-1 (Cox-1) and interleukin (IL)-1 expressions in the liver, Cas-3, Cox-1 and IL-3 expressions in the kidney were observed. Conclusion: Following SAH, in addition to damage to brain tissue, peripheral tissues such as the lung, kidney, and liver can also be damaged through inflammation and apoptosis.

4 June 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAydın Talat Baydar
Aydın Talat Baydar
MCMusa Canan
Musa Canan
RTRumeysa Taner
Rumeysa Taner
OKOznur Kolay
Oznur Kolay
AMAdem MİLLETSEVER
Adem MİLLETSEVER
OOOzlem Ozmen
Ozlem Ozmen
Subarachnoid hemorrhage (SAH) triggers intense neuroinflammatory and apoptotic cascades that contribute to secondary brain injury, delayed cerebral ischemia, and poor neurological outcomes. Inflammatory mediators such as interleukin-6 (IL-6) and signal transducer and activator of transcription 3 (STAT3) amplify oxidative stress and endothelial dysfunction, whereas suppression of the hypoxia-inducible factor-1α (HIF-1α)/endothelial nitric oxide synthase (eNOS)/vascular endothelial growth factor (VEGF) pathway impairs hypoxic adaptation and neuronal survival. L-arginine (L-ARG), a nitric oxide precursor, and radiofrequency electromagnetic field (RF-EMF) therapy each exhibit neuroprotective potential through anti-inflammatory and microcirculatory mechanisms. Adult male Wistar rats were assigned to Control, SAH, SAH + L-ARG, SAH + RF, and SAH + L-ARG + RF groups (n = 8 per group). SAH was induced by autologous arterial blood injection into the cisterna magna, followed by daily treatment with L-ARG (500 mg/kg, p.o.) and/or RF-EMF (27.12 MHz, 30 min/day) for seven days. SAH markedly increased NF-κB, TNF-α, Cas-3, IL-6, and STAT3 expression while suppressing HIF-1α, eNOS, and VEGF transcripts. Combined treatment was associated with the most pronounced improvements across measured molecular markers, including reduced inflammation and apoptosis and normalization of mitochondrial regulators (↓BAX, ↑BCL-2). These findings suggest that combined L-ARG and RF-EMF exposure is associated with attenuation of inflammation and apoptosis-related molecular injury after experimental SAH; however, functional and perfusion-based outcomes are required before therapeutic efficacy can be inferred.